Cellular uptake of a novel cytotoxic agent, cryptophycin-52, by human THP-1 leukemia cells and H-125 lung tumor cells

International Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 869-873

  Chen, Ben D M ^a   Nakeff, Alex ^a   Valeriote, Fred ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; COLCHICINE; CRYPTOPHYCIN 52; CYTOTOXIC AGENT; DOXORUBICIN; PACLITAXEL; TRITIUM; TUBULIN; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; BINDING AFFINITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYANOBACTERIUM; DRUG UPTAKE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LUNG TUMOR; MICROTUBULE; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA; LUNG NEOPLASMS; PEPTIDES, CYCLIC; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0031871128     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980911)77:6<869::AID-IJC12>3.0.CO;2-X     Document Type: Article

References (19)

1. BAI, R., SCHWARTZ, R.E., KEPLER, J.A., PETTIT, G.R. and HAMEL, E., Characterization of the interaction of cryptophycin 1 with tubulin: binding in the vinca domain, competitive inhibition of dolastain 10 binding, and unusual aggregation reaction. Cancer Res., 56, 4398-4406 (1996).
2. BAI, R., TAYLOR, G.F., SCHMIDT, J.M., WILLIAMS, M.D., KEPLER, J.A., PETTIT, G.R. and HAMEL, E., Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions. Mol. Pharmacol., 47, 965-976 (1995).
3. BARROW, R.A., HEMSCHEIDT, T., LIANG, J., PAIK, S., MOORE, R.E. and TIUS, M.A., Total synthesis of cryptophycins. Revision of the structures of cryptophycins A and C. J. Amer. chem. Soc., 117, 2479-2490 (1995).
4. BRADLEY, G. and LING, V., P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev., 13, 223-233 (1994).
5. CORBETT, T.H. and 31 OTHERS, Tumor models and the discovery and secondary evaluation of solid tumor active agents. Int. J. Pharmacol., 33, 1-21 (1995).
6. FORD, J.M., YANG, J.M. and HAIT, W.N., P-glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal. Cancer Treat. Res., 87, 3-38 (1996).
7. HAMEL, E., Interactions of tubulin with small ligands. In: J. Avila (ed.), Microtubule proteins, pp. 89-191, CRC Press, Boca Raton, FL (1990).
8. KERKSIEK, K., MEJILLANO, M.R., SCHWARTZ, R.E., GEORG, G.I. and HIMES, R.H., Interaction of cryptophycin 1 with tubulin and microtubules. FEBS Lett., 377, 59-61 (1995).
9. KUHL, J.S., KRAJEWSKI, S., DURAN, G.E., REED, J.C. and SIKIC, B.I., Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia. Brit. J. Cancer, 75, 268-274 (1997).
10. LUDUEÑA, R.F., ROACH, M.C., PRASAD, V., PETTIT, G.R., CICHACZ, Z.A. and HERALD, C.L., Interaction of three sponge-derived macrocyclic lactone polyethers (Spongistatin 3, Halistatins 1 and 2) with tubulin. Drug Develop, Res., 35, 40-48 (1995).
11. MOOBERRY, S.L., TAOKA, C.R. and BUSQUETS, L., Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site. Cancer Lett., 107, 53-57 (1996).
12. MOORE, R.E., Cyclic peptides and depsipeptides from cyanobacteria: a review. J. Industr. Microbiol., 16, 134-143 (1996).
13. NOOTER, K. and STOTER, G., Molecular mechanisms of multidrug resistance in cancer chemotherapy. Pathol. Res. Pract., 192, 768-780 (1996).
14. POLIN, L. and 13 OTHERS, Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice. Invest. New Drugs, 15, 99-108 (1997).
15. ROSENTHAL, H.E., Graphical method for the determination and presentation of binding parameters in a complex system. Anal. Biochem., 20, 525-532 (1967).
16. SMITH, C.D. and ZHANG, X., Mechanism of action of cryptophycin: interaction with the Vinca alkaloid domain of tubulin. J. biol. Chem., 271, 6192-6198 (1996).
17. SMITH, C.D., ZHANG, X., MOOBERRY, S.L., PATTERSON, G.M.L. and MOORE, R.E., Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. Cancer Res., 54, 3779-3784 (1994).
18. SUBBARAJU, G.V., GOLAKOTI, T., PATTERSON, G.M. and MOORE, R.E., Three new cryptophycins from Nostoc sp. GSV 224. J. nat. Prod., 60, 302-305 (1997).
19. XIA, H., BLEICHER, R.J., GUPTA, V., ZAREN, H.A. and SINGH, S.V., Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line. Int. J. Cancer, 70, 606-611 (1997).